Towards developing standardized protocols for evaluation of cellular mucosal immune responses - Recommendations from a DAIDS/NIH workshop, June 15-16, 2009.
Although 80% of HIV infections occur through mucosal routes and vaccine strategies need to be designed for inducing protective immune responses at the site of the viral entry, it has proven to be very challenging to measure these responses. A 2-day workshop was convened by Division of AIDS, National Institutes of Health on June 15-16, 2009 to address the challenges encountered in the evaluation of mucosal T cell immune responses. The goal of the workshop was to obtain recommendations/consensus for developing standardized protocols for the assessment of mucosal immunity. This report summarizes the areas of consensus and recommendations that should assist in developing standardized methodologies for the evaluation of mucosal immune responses.
Mehra
V
V
Preclinical Research and Development Branch, Vaccine Research Program, Division of AIDS, NIAID, NIH, HHS, USA.
Musib
R
R
Schito
M L
ML
D005260:Female; D015658:HIV Infections / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology*; D018928:Immunity, Mucosal / Q000276:immunology*; D008297:Male; D009092:Mucous Membrane / Q000276:immunology; D009316:National Institutes of Health (U.S.); D014481:United States